Catalyst
Slingshot members are tracking this event:
Aurinia (AUPH) to Present Phase 2b AURA-LV 48-Week Data Evaluating Voclosporin in Lupus Nephritis (LN) at the National Kidney Foundation (NKF) Annual Meeting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AUPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 20, 2017
Occurred Source:
http://ir.auriniapharma.com/press-releases/detail/85/aurinia-releases-additional-48-week-data-from-the-aura-lv
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2b, Aura-lv, 48-week Data, Voclosporin, Lupus Nephritis, Ln, Nkf, Annual Meeting, National Kidney Foundation
